European Pharmaceutical Review

MAY 22, 2023

Smart contracts, which are essential for easing international trade and logistics operations, can enable the user to track fake returns to the producer and supplier using RFID tags. Blockchain offers the possibility of non-modifiable data uploading with traceability and low-cost data storage. In conclusion, Kordestani et al.

90

90

Pharmaceutical Technology

NOVEMBER 7, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. On a regional level, these roles were hardest to fill in Europe, with related jobs that were taken offline in Q3 2022 having been online for an average of 42.8

84

84

Pharmaceutical Technology

NOVEMBER 9, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 2.9% in October 2022.

Pharmaceutical Companies 69

Pharmaceutical Companies Pharmaceutical Companies 69

Pharmaceutical Technology

JULY 6, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 8.2% in June 2022.

Pharmaceutical Companies 64

Pharmaceutical Companies Pharmaceutical Companies 64

Pharmaceutical Technology

JULY 8, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. On a regional level, these roles were hardest to fill in Europe, with related jobs that were taken offline in Q1 2022 having been online for an average of 35.1

59

59

Pharmaceutical Technology

JUNE 27, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 2.8% in May 2022.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies 59

pharmaphorum

SEPTEMBER 15, 2020

Digitally native brands are typically agile businesses from the ground up, and agility and flexibility are part of their core makeup,” says Joe Holmes, vice president, marketing services, US at Tag. Jeremy Richter, Tag. Build on the rapid responses to COVID-19. Jeremy Richter – director of regulatory affairs.

Communication 121

Communication Documentation Labelling Vaccines 121

Pharmaceutical Technology

AUGUST 1, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 5.8% in July 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JULY 27, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 0.6% in June 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JULY 18, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 6.1% in June 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JULY 13, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 11% in June 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JULY 4, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 6.3% in June 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JUNE 23, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 0.6% in May 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

NOVEMBER 8, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 0.9% in October 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

AUGUST 17, 2020

In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Joanna Carlish, managing director, financial services, Tag Americas. Virtual connections.

Communication 93

Communication Insurance Packaging Pharmaceutical Companies 93

Pharmaceutical Technology

SEPTEMBER 21, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 5.6% in August 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

AUGUST 10, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 5.8% in July 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

AUGUST 8, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 3.3% in July 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

AUGUST 3, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 0.9% in July 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JULY 20, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 0.9% in June 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JULY 11, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 4.7% in June 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

APRIL 14, 2022

million price tag. bluebird pulled it off the market last year however and retreated from the European market, saying the pricing and reimbursement environment was too hostile to make its business there viable. The gene therapy has already been approved for marketing in the EU and UK, where it was launched at a cost of around $1.7

FDA 63

FDA 63

DiversifyRx

JUNE 23, 2023

It offers segmentation, tagging, and scheduling capabilities. THE INTERMEDIATE CRM If you’ve been in business for a while and have an email list of 10,000 or more subscribers, I’d look into ACTIVE CAMPAIGN. They have an excellent support team available 24/7, which is particularly helpful if you’re a global business.

52

52

Roots Analysis

JANUARY 28, 2024

Velocity: Big Data needs to be handled promptly as businesses generate data at an unprecedented speed, driven by the growing adoption of Internet of Things (IoT), and technologies, such as RFID tags, sensors, and smart meters are used to deal with the high velocity of data in real-time.

Health and Personal Care Stores 40

Health and Personal Care Stores Medical Records Hospitals 40

ISPE

DECEMBER 1, 2022

Winner of the ISPE Italy Affiliate’s Women in Pharma® Graziella Molinari Award in 2021, thanks to her project for the inclusion of #smart tags in a site production in order to improve not only efficiency, but also quality and compliance in a 4.0 trillion dollars in global turnover. Micaela Prati. perspective. .

98

98

The Social Pharmacist

AUGUST 2, 2022

SEO-friendly pharmacy businesses or websites benefit from higher visitor traffic, improved brand awareness, and increased customer conversion rates. If you manage a social media page, posting your newest content lets people find your business. A successful SEO campaign helps pharmacy businesses drive traffic to their website.

52

52

pharmaphorum

SEPTEMBER 29, 2021

Oliver Stohlmann’s Corporate Survival Hacks series draws on his experiences of working in local, regional and global life science communications to offer some little tips for enjoying a big business career. If you need to phrase your message off-business hours, tag your draft for later delivery and release it during office hours.

Communication 118

Communication 118

Pharmaceutical Technology

JULY 14, 2022

Due to the high price tags associated with these speciality medicines, innovators have naturally favoured big markets with high GDP such as the US and EU-5 (Germany, France, Spain, Italy, and the UK). Our pharmaceutical partners see us as an extension of their own businesses rather than a transactional partner.”.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies Hospitals 59

pharmaphorum

AUGUST 18, 2022

The US approval comes three years after Zynteglo (betibeglogene autotemcel) was approved for the same indication in Europe, and subsequently withdrawn after bluebird concluded that it wasn’t possible to build a commercially viable business for the gene therapy as the pricing and reimbursement environment there was too “hostile.”

FDA 52

FDA Insurance 52

pharmaphorum

JANUARY 11, 2021

US biotech bluebird bio has announced plans to split into two this year, with a separate oncology business spinning off as the company prepares to bring its products to market. million price tag. Zynteglo is already in beta-thalassemia in Europe, where the company will seek to expand access despite its hefty $1.8

FDA 60

FDA 60

Viseven

NOVEMBER 30, 2022

Geetha Thiagarajan , CTO Lifesciences and Healthcare business unit,? And if you look at the pharma business, in particular, it has been traditionally a little close to forming partnerships. It makes sense for pharma businesses to have technology partners rather than reinvent all of this.

52

52

pharmaphorum

DECEMBER 2, 2020

Both in their mid-twenties, the two men set up what was initially a fine chemicals business in a Brooklyn factory, using a loan from Pfizer’s father as capital. The deal seemed to be a precursor to Pfizer’s plans to separate its patent-protected medicines business from its off-patent portfolio.

Compounding 128

Compounding Vaccines Pharmaceutical Companies Pharmaceutical Companies 128

Pharmaceutical Technology

FEBRUARY 22, 2023

Both drugs come with a high price tag. This case has broader implications for pharma as an industry, which explains the interest from other businesses. Both drugs are monoclonal antibodies that inhibit the protein PCSK9. Since April 2020, Sanofi is responsible for Praluent outside of the US, while Regeneron handles its sale in the US.

FDA 104

FDA 104

pharmaphorum

FEBRUARY 22, 2021

One UK company that could be affected greatly by that is Oxford BioMedica , which has built a business around its LentiVector delivery platform used in Kymriah and other emerging therapies, according to Jefferies. million in Europe. The post Zynteglo halt re-ignites viral vector safety concerns; analysts appeared first on.

Immunization 52

Immunization 52

Dr. Jamie Hardy: The Lifestyle Pharmacist

AUGUST 20, 2020

If you’re nervous about the responsibilities of taking care of your plants, trust me when I tell you that these plants require little attention and are ideal for beginners and even busy professionals like you! Be sure to tag me using the hashtags #FABSQUAD #PlantSquad.

52

52

PharmaShots

MARCH 9, 2023

Education: She graduated from Cornell University with a master’s in Business Administration and Management. Birthplace: Belén was born in Almansa (Spain) Additional Information: Merck became a significant international participant in immunology, oncology, and immune oncology under her leadership of the Healthcare business.

FDA 40

FDA Pharmaceutical Companies Pharmaceutical Companies Immunization 40

pharmaphorum

NOVEMBER 27, 2022

Instead, companies should be looking towards a future where speed and agility are the key components in developing business resilience, rather than a reliance on inventory stockpiles and large quality assured batches. Automation will be a large part of this long-term vision.

Communication 105

Communication Pharmaceutical Companies Pharmaceutical Companies Packaging 105